Impact of the treatment of patients with acute esophageal perforation in survival
Keywords:
esophageal perforation, reinforced suture, mediastinoclysis, survival, secondary health care.Abstract
A descriptive and cross-sectional serial cases study, of 35 patients with acute esophageal perforation, discharged from the General Surgery Service of “Saturnino Lora Torres" Teaching Clinical Surgical Provincial Hospital in Santiago de Cuba was carried out, from January, 1990 to September, 2014, aimed at characterizing them according to the epidemiologic, clinical and therapeutic variables of interest. In the series the strange body of difficult extraction (42.8%), thoracic localization (51.4%) and surgical treatment prevailed in all the patients. On the other hand, the reinforced esophagus suture was used in those affected with less than 24 hours of natural course and mediastinal cavity drainage and mediastinoclysis by median sternotomy in those with more than 24 hours of natural course, which diminished in 50% the mortality regarding the drainage and simple mediastinal cavity debridement. It was concluded that early surgical treatment is vital to improve the survival and terminal esophageal exclusion in the neck, as well as mediastinal cavity wash by means of mediastinoclysis, are effective in the patients with acute mediastinitis due to this cause.
Downloads
References
2. Altorjay A, Kiss J, Vörös A, Szirányi E. The role of esophagectomy in the management of esophageal perforations. Ann Thorac Surg. 1998;65(5):1433-6.
3. Martínez Vallinaa P, Espinosa Jiménez D, Hernández Pérez L, Triviño Ramírez A. Mediastinitis. Arch Bronconeumol. 2011;47(Suppl 8):32-6.
4. Mejía Melgar EM, Dajer Fadel WL, Tortolero Sánchez CR, Ramírez Montaño L, Borrego Borrego R, Navarro Reynoso, et al. Tratamiento exitoso de un caso de perforación esofágica posterior. Rev Med Hosp Gen México. 2014 [citado 23 Oct 2015];77(1):37-42. Disponible en: http://www.elsevier.es/en-revista-revista-medica-del-hospital-general-325-articulo-tratamiento-exitoso-un-caso-perforacion-90292739
5. Smith PW, Salomone LJ, Hanks JB. Surgical treatment of benign esophageal diseases. Texbook of surgery 19th. Philadelphia: Saunders Elsevier; 2012.
6. Helton WB, Unnikrishnan R, Gal T. Cervical esophageal perforation and cricopharyngeal dysfunction. Ear Nose Throat J. 2011; 90(3):8-10.
7. San Norberto EM, Taylor J, Estévez I, Fuente R, Carrera S, Vaquero C. Fístula aortoesofágica secundaria a endoprótesis torácica: a propósito de 3 casos y revisión de la literatura. Angiología. 2013;65(3):102-8.
8. Uhrenholt L, Freeman MD, Jurik AG, Jensen LL, Gregersen M, Boel LW, et al. Esophageal injury in fatal rear-impact collisions. Forensic Sci Int. 2011; 206(1-3):52-7.
9. Gottumukkala S, Raju, MD. Esophageal perforations. Gastroenterol Hepatol. 2012; 8(8):548–51.
10. Antezana W, Burgos MH, Camacho J, Muñoz H, Dorado CH, Araya L. Perforación esofágica: presentación de caso. RMHV. 2008 [citado 12 Oct 2015];1(1):28-34. Disponible en: http://www.revistasbolivianas.org.bo/scielo.php?pid=S9999-99992008000100010&script=sci_arttext
11. Morales U, Uribe J, Gómez F. Factores pronóstico en perforaciones esofágicas. Rev Cir Perú. 2009;16(1):77-80.
12. Ferguson M. Reparación primaria de una perforación esofágica. En: Atlas de cirugía de tórax. Philadelphia: Elsevier;2009.
13. Braghetto M, Rodríguez N, Csendes J, Korn B. Perforación esofágica. Experiencia clínica y actualización del tema. Rev Méd Chile. 2005;133(10):1233-41.
14. Okonta KE, Kesieme EB. Is oesophagectomy or conservative treatment for delayed benign oesophageal perforation the better option? Interact Cardiovasc Thorac Surg. 2012;15(3):509-11.
15. Roig García J, Gironès Vilà J, García Oria M, Codina Barreras AB, Rodríguez Hermosa J, Codina Cazador A. Exclusión esofagofúndica temporal en la mediastinitis grave por perforación esofágica. Cir Esp. 2003;73(6):351-3.
Published
How to Cite
Issue
Section
License
All the articles can be downloaded or read for free. The journal does not charge any amount of money to the authors for the reception, edition or the publication of the articles, making the whole process completely free. Medisan has no embargo period and it is published under the license of Creative Commons, International Non Commercial Recognition 4.0, which authorizes the copy, reproduction and the total or partial distribution of the articles in any format or platform, with the conditions of citing the source of information and not to be used for profitable purposes.
